NCT04089215 2023-11-24CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins LymphomaShanghai Ming Ju Biotechnology Co., Ltd.Phase 2 Unknown82 enrolled
NCT05727683 2023-02-14CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic LeukemiaShanghai Ming Ju Biotechnology Co., Ltd.Phase 1 Unknown33 enrolled